ASCO 2024: Palbociclib, Pembrolizumab, & Endocrine therapy in HR+/HER2- locally advanced or metastatic breast cancer (MBC) – Alexis LeVee, MD – City of Hope ASCO Annual Meeting 2 Mins Read212 Author: Dr. Alexis LeVee, City of Hope At the ASCO 2024 conference, Dr. Alexis LeVee from City of Hope presented…
